Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results
Date:11/6/2013

CHESTERBROOK, Pa., Nov. 6, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for the quarter ending September 30, 2013.  The Company also highlighted select commercial, regulatory and clinical development progress in the third quarter of 2013 and updated guidance for full year 2013.

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )

For the quarter ended September 30, 2013, Auxilium reported net revenues of $108.1 million, compared to net revenues of $71.0 million in the third quarter of 2012, an increase of 52%.  For the third quarter of 2013, XIAFLEX® U.S. net revenues increased by 20% over the comparable 2012 period to $15.9 million and U.S. Testim® net revenues decreased by 7% to $50.7 million.  Revenues from Auxilium's recently acquired subsidiary, Actient Holdings LLC, resulted in net revenues of $38.3 million for the third quarter of 2013.  This included TESTOPEL® net revenues of $20.6 million and Edex® net revenues of $8.0 million for the third quarter of 2013.

Auxilium reported net income for the quarter ending September 30, 2013 of $8.5 million, or $0.17 per share (basic and fully diluted) on a non-GAAP basis compared to a non-GAAP net loss of ($6.9) million, or ($0.14) per share (basic and fully diluted)  for the quarter ending September 30, 2012.  On a U.S. GAAP basis, Auxilium reported net loss of ($28.9) million, or ($0.59) per share (basic and fully diluted), compared to a net loss of ($10.5) million, or ($0.21) per share (basic and fully diluted), reported for the third quarter of 2012.  The foregoing non-GAAP financial measures should not be relied upon as
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... NEW YORK , Sept. 3,  2015 /PRNewswire/ ... types of vision care products considered for this ... sunglasses, and readers. These products are primarily used ... purposes. Products such as Rx lenses and contact ... non-Rx sunglasses, and readers are cosmetic products that ...
(Date:9/3/2015)... 3, 2015 About cardiovascular ... involves narrowing or blockage of blood vessels. Cardiac ... smoking, high cholesterol, and high blood pressure. Coronary ... and heart failure are some of the major ... vessels, especially coronary arteries, is one of the ...
(Date:9/3/2015)... , Sept. 3, 2015 Nevro Corp. (NYSE: ... is providing innovative evidence-based solutions for the treatment of ... presenting at the Morgan Stanley Global Healthcare Conference on ... Nevro management is scheduled to present at ... a live audio webcast, accessible in the "Investors" section ...
Breaking Medicine Technology:Vision Care Market in the US 2015-2019 2Global Cardiovascular Implants Market 2015-2019 2
... Oct. 19, 2009 Amylin Pharmaceuticals, Inc. (Nasdaq: ... obesity program will be presented at Obesity 2009, the ... be held in Washington, D.C. October 24-28. Phase 2 ... be the subject of a late-breaking oral presentation. Obesity ...
... , SILVER SPRING, Md., Oct. 19 The U.S. Food ... to be approved for kidney cancer since 2005. , (Logo: ... oral medication that interferes with angiogenesis, the growth of new ... , Votrient is intended for people with advanced renal ...
Cached Medicine Technology:Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 2Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 3Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 4Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009 5FDA Approves New Treatment for Advanced Form of Kidney Cancer 2
(Date:9/4/2015)... ... 2015 , ... Georgia Insurance Advisors, a locally owned insurance ... provide for the family of Grace, a young local girl battling restrictive cardiomyopathy. ... to diastolic dysfunction – the inability to adequately move blood through the circulatory ...
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar ... (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary Supplements and Supply ... constantly evolving in the consumer goods industry, it can be difficult for companies ...
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts ... the Year” awards at this year’s Microsoft Worldwide Partner Conference that was held ... the Year” Award Winner for Data Platform services, the 2015 HP and Microsoft ...
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... ... announces that CEREC technology is now available at CitiDent. CEREC is a newer ... In addition to saving time for patients by eliminating the need for multiple ...
(Date:9/4/2015)... ... 04, 2015 , ... Mike Day, a former Navy SEAL who was shot ... World Championships in Kona on October 10th. , Mike is running the race to ... combat and the cutting-edge treatments that restore their quality of life. More ...
Breaking Medicine News(10 mins):Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2
... University School of Medicine (BUSM) have demonstrated that commensal ... inducers of human airway epithelial cell responses as compared ... a Neisserial outer membrane component appears to play a ... with a receptor on the surface of human airway ...
... Mozes HealthDay Reporter , MONDAY, Nov. 22 ... well-known antioxidant cousin, alpha-carotene, in fruits and vegetables can ... heart disease and cancer, new research suggests. ... -- because of the red, yellow and orange coloring ...
... Doctors at the University of Colorado School of Medicine were ... of a 64-year-old Colorado man. They extracted cells from the ... the biopsy results were inconclusive. Even a few months ... remove all or part of the thyroid. At least this ...
... become aware of the dangers of excessive fructose in diet. ... the Journal of the American Society of Nephrology ... may be. Richard J. Johnson, MD and Takahiko ... Colorado) provide a concise overview of recent clinical and experimental ...
... , MONDAY, Nov. 22 (HealthDay News) -- Increased ... United States billions of dollars a year in medical ... Medical Expenditure Panel Survey, the investigators estimated how reductions ... related conditions would affect health care spending. The ...
... Holohan HealthDay Reporter , MONDAY, Nov. 22 ... can fuel each other, a new study shows. ... subjects who were depressed had a much higher risk ... significantly higher risk of depression, compared to healthy study ...
Cached Medicine News:Health News:BUSM investigates cellular mechanisms leading to immune response in airway epithelium 2Health News:Eat Your Fruits & Veggies for Longer Life 2Health News:Eat Your Fruits & Veggies for Longer Life 3Health News:Genomic 'markers' may head off thousands of thyroid surgeries 2Health News:Disease Prevention Could Save U.S. Billions of Dollars Annually 2Health News:Diabetes, Depression Can Be Two-Way Street 2Health News:Diabetes, Depression Can Be Two-Way Street 3
... transmitted through sorted fiberglass bundles ... transmit it to a user's ... designed for rough, industrial handling ... low cost if they should ...
... for Neurosurgery. The neuroview family of ... minimally invasive procedures. Available in a ... working channels for instrument use and ... and steerable tip, the surgeon can ...
The new Zeppelin Generation of High Speed Motordrill Systems with leading technology, innovative ergonomics, and extremely lightweight design is milestones ahead for precise and rapid bone trepanatio...
The Hilan pneumatic high speed drill system consists of a pneumatic motor and drill with various cutting attachments....
Medicine Products: